TABLE 6.
Maternal outcomes
| Parameter | EPA-rich fish oil (n = 39) | DHA-rich fish oil (n = 38) | Placebo (n = 41) | Significance |
|---|---|---|---|---|
| Gestational age at delivery (wks), mean (SD) | 39.1 (1.5) | 40.4 (0.9) | 39.1 (1.5) | < .0001a–c |
| GDM, n (%) | 7 (18) | 1 (3) | 2 (5) | .06d |
| Gestational hypertension or preeclampsia, n (%) | 8 (21) | 2 (5) | 5 (12) | .12d |
| Induced labor, n (%) | 15 (38) | 12 (32) | 8 (20) | .20d |
| Estimated blood loss (mL), mean (SD) | 507 (481) | 508 (325) | 454 (296) | .81a |
| Cesarean section, n (%) | 10 (26) | 12 (32) | 11 (28) | .084d |
| Spontaneous vaginal delivery, n (%) | 25 (64) | 25 (66) | 28 (70) | .88d |
| Operative vaginal delivery, n (%) | 4 (10) | 1 (3) | 1 (3) | .32d |
ANOVA, analysis of variance; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; GDM, gestational diabetes mellitus; NS, not significant; SD, standard deviation.
a
One-way ANOVA;
b
Tukey’s studentized range test;
c
The DHA group was significantly greater than both the EPA group and the placebo group;
d
Fisher exact test.